Related references
Note: Only part of the references are listed.Biosynthesis of heparan sulfate in EXT1-deficient cells
Megumi Okada et al.
BIOCHEMICAL JOURNAL (2010)
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
Rogier M. Reijmers et al.
BLOOD (2010)
Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells
Tatiana Y. Prudnikova et al.
CANCER CELL INTERNATIONAL (2010)
Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains
F. Zong et al.
CELL PROLIFERATION (2010)
Mechanisms of resistance to antiangiogenesis therapy
Faisal Azam et al.
EUROPEAN JOURNAL OF CANCER (2010)
Targeting the transforming growth factor-beta signaling pathway in human cancer
Nagathihalli S. Nagaraj et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications
Yasushi Toh et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Fibroblast Growth Factor Receptor 2-Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma
Chunyu Zhang et al.
CLINICAL CANCER RESEARCH (2009)
Lack of L-Iduronic Acid in Heparan Sulfate Affects Interaction with Growth Factors and Cell Signaling
Juan Jia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis
Renato V. Iozzo et al.
MOLECULES AND CELLS (2009)
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Jason J. Zoeller et al.
MATRIX BIOLOGY (2009)
Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells
Fang Zong et al.
PLOS ONE (2009)
Diverse Cell Signaling Events Modulated by Perlecan
John M. Whitelock et al.
BIOCHEMISTRY (2008)
The heparanome and regulation of cell function: structures, functions and challenges
Alessandro Ori et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Heparan sulphate biosynthesis and disease
Satomi Nadanaka et al.
JOURNAL OF BIOCHEMISTRY (2008)
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
Takurna Aikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC)
Wolfgang M. Brueckl et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Decreased expression of human D-glucuronyl C5-epimerase in breast cancer
Elvira Grigorieva et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density
Krista R. Catlow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of different proteoglycans in human breast tumors
T. Yu. Eshchenko et al.
BIOCHEMISTRY-MOSCOW (2007)
Syndecans in wound healing, inflammation and vascular biology
Annika N. Alexopoulou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis
Birgitte Vrou Offersen et al.
LUNG CANCER (2007)
Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer
Christine L. Hann et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Basement membrane proteoglycans: From cellar to ceiling
RV Iozzo
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
The metastasis associated protein S100A4: role in tumour progression and metastasis
DM Helfman et al.
BRITISH JOURNAL OF CANCER (2005)
Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis
DT Merrick et al.
LUNG CANCER (2005)
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells
S Ropero et al.
HUMAN MOLECULAR GENETICS (2004)
Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality
JP Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor
H Kim et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21
AI Protopopov et al.
JOURNAL OF GENE MEDICINE (2002)
Heparan sulfate proteoglycans and cancer
FH Blackhall et al.
BRITISH JOURNAL OF CANCER (2001)
The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators
DF Crawford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4-N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/heparin biosynthesis
BT Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate
JP Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The elusive functions of proteoglycans: In vivo veritas
AD Lander et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
